Navigation Links
First comprehensive guidelines for managing anaplastic thyroid cancer published in Thyroid journal
Date:11/7/2012

New Rochelle, NY, November 7, 2012Anaplastic thyroid cancer is a rare form of thyroid tumor, but it is also the most deadly. Newly developed evidence-based recommendations for the diagnosis, treatment, and long-term monitoring and follow-up care of patients with this extremely aggressive form of thyroid cancer are published in Thyroid (http://www.liebertpub.com/thy), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). The Guidelines, prepared by the American Thyroid Association Anaplastic Thyroid Cancer Guidelines Task Force, are available free online on the Thyroid (http://www.liebertpub.com/thy) website.

Robert C. Smallridge, MD, Chair of the ATA Task Force, from the Mayo Clinic, Jacksonville, FL, and coauthors of the "American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer (http://online.liebertpub.com/doi/full/10.1089/thy.2012.0302)" emphasize the importance of rapid diagnosis and evaluation of this aggressive tumor, establishing treatment goals, and employing a multidisciplinary team approach for optimal patient management. The comprehensive Guidelines cover recommended approaches to treatment including surgery, radiotherapy, systemic therapy, and supportive care. They also offer guidance on managing patients with advanced/metastatic disease, surveillance and long-term monitoring, palliative care options, and ethical issues including end-of-life care.

"The American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer is a remarkable and comprehensive document that distills the literature and taskforce expertise into a useful guide for providers of patients with this aggressive cancer. The focused therapeutic approaches, as well as the inclusion of palliative care and ethical issues into this document, is a real advance for our field," says Bryan R. Haugen, MD, President of the ATA and Professor of Medicine and Pathology, Head, Division of Endocrinology, Metabolism & Diabetes, Mary Rossick Kern and Jerome H. Kern Chair in Endocrine Neoplasms Research, University of Colorado School of Medicine.

"The Anaplastic Thyroid Cancer Guidelines are a unique contribution to the endocrine literature," says Charles H. Emerson, MD, Editor-in-Chief of Thyroid and Professor Emeritus of Medicine at the University of Massachusetts School of Medicine. "The Guidelines demand to be read now, not learned during the emergency that is anaplastic thyroid cancer."


'/>"/>
Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related medicine news :

1. First gene therapy study in human salivary gland shows promise
2. Clinical trials for first-ever human hookworm vaccine advance
3. Handshakes Matter for First Impressions, Brain Study Confirms
4. IU researchers report first effective treatment of tumors arising from common genetic disease NF1
5. Caffeines effect on the brains adenosine receptors visualized for the first time
6. Black Breast Cancer Patients May Have Higher Death Risk in First 3 Years
7. New pediatric heart failure guidelines a first in Canada
8. Increased risk for breast cancer death among black women greatest during first 3 years postdiagnosis
9. First FDA approved subcutaneous implantable defibrillator available for patients
10. First web-based prostate cancer database launches
11. BIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First comprehensive guidelines for managing anaplastic thyroid cancer published in Thyroid journal
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... of ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and ... may have been used to remove decayed dental matter, and that teeth were then ...
(Date:4/21/2017)... ... 21, 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD ... a benign bony lump located on the forehead usually attributed to a facial fracture. ... and pain. Dr. Shah has discovered an approach that is minimally invasive. He is ...
(Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The ... specialty and orphan brands can only be achieved when the needs and beliefs of ... at the heart of a true partnership between our agency and our clients to ...
(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility ... Hong Kong to support teaching, learning and research. It is also the largest research ... Hong Kong. , With an area of 620 square metres and more than ...
(Date:4/21/2017)... ... April 21, 2017 , ... Airway Management, the medical device ... highly regarded and well renowned Asian distributor, Discovery Sleep. The agreement ... Pillow Mask, and will stabilize and strengthen Airway’s presence with a dedicated, reputable ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
(Date:4/18/2017)... -- Spero Therapeutics, LLC, a biopharmaceutical company founded to develop ... present preclinical data supporting the use of SPR741 combination ... infections at the 27th European Congress of Clinical Microbiology ... Vienna, Austria . ... "Our ongoing preclinical research helps ...
Breaking Medicine Technology: